Macular holes: Classification, epidemiology, natural history and treatment

Acta Ophthalmologica Scandinavica

Volumn 80, Issue 6, 2002, Pages 579-587

  la Cour, Morten ^a   Friis, Jakob ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Epidemiology; Macular hole; Macular hole surgery; Natural history; Pathogenesis; Vitrectomy

Indexed keywords

DENMARK; DISEASE CLASSIFICATION; ENDOPHTHALMITIS; HUMAN; PATHOGENESIS; PIGMENT EPITHELIUM; PREVALENCE; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA HOLE; REVIEW; RISK ASSESSMENT; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

DENMARK; HUMANS; PREVALENCE; RETINAL PERFORATIONS; RISK FACTORS; SEX DISTRIBUTION;

EID: 0036914281     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2002.800605.x     Document Type: Review

References (96)

1. Aaberg TM (1970): Macular holes: a review. Surv Ophthalmol 15: 139-162.
2. Akiba J, Konno S & Yoshida A (1999): Retinal detachment associated with a macular hole in severely myopic eyes. Am J Ophthalmol 128: 654-655.
3. Akiba J, Quiroz MA & Trempe CL (1990a): Role of posterior vitreous detachment in idiopathic macular holes. Ophthalmology 97: 1610-1613.
4. Akiba J, Yoshida A & Trempe CL (1990b): Risk of developing a macular hole. Arch Ophthalmol 108: 1088-1090.
5. Azzolini C, Patelli F & Brancato R (2001): Correlation between optical coherence tomography data and biomicroscopic interpretation of idiopathic macular hole. Am J Ophthalmol 132: 348-355.
6. Banker AS, Freeman WR, Azen SP & Lai MY (1999): A multicentred clinical study of serum as adjuvant therapy for surgical treatment of macular holes. Vitrectomy for Macular Hole Study Group. Arch Ophthalmol 117: 1499-1502.
7. Banker AS, Freeman WR, Kim JW, Munguia D & Azen SP (1997): Vision-threatening complications of surgery for full thickness macular holes. Vitrectomy for Macular Hole Study Group. Ophthalmol 104: 1442-1452.
8. Benson WE, Cruickshanks KC, Fong DS, Williams GA, Bloome MA, Frambach DA, Kreiger AE & Murphy RP (2001): Ophthalmic technology assessment. Surgical management of macular holes. A report by the American Academy of Ophthalmology. Ophthalmology 108: 1328-1335.
9. Bopp S, Lucke K & Hille U (1997): Peripheral visual field loss after vitreous surgery for macular holes. Graefes Arch Clin Exp Ophthalmol 235: 362-371.
10. Brooks HL Jr (2000): Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 107: 1939-1948.
11. Byhr E & Lindblom B (2000): Macular hole surgery without routine membrane excision or use of adjuvants. Acta Ophthalmol Scand 78: 451-455.
12. Casuso LA, Scott IU, Flynn HW Jr, Gass JD, Smiddy WE, Lewis ML & Schiffman J (2001): Long-term follow-up of unoperated macular holes. Ophthalmology 108: 1150-1155.
13. Cheng L, Freeman WR, Ozerdem U, Song MK & Azen SP (2000): Prevalence, correlates and natural history of epiretinal membranes surrounding idiopathic macular holes. Vitrectomy for Macular Hole Study Group. Ophthalmol 107: 853-859.
14. Chew EY, Sperduto RD, Hiller R et al. (1999): Clinical course of macular holes: the Eye Disease Case-Control Study. Arch Ophthalmol 117: 242-246.
15. Christmas NJ, Smiddy WE & Flynn HW Jr (1998): Reopening of macular holes after initially successful repair. Ophthalmology 105: 1835-1838.
16. Da Mata AP, Burk SE, Riemann CD, Rosa RH Jr, Snyder ME, Petersen MR & Foster RE (2001): Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology 108: 1187-1192.
17. De Bustros S (1994): Vitrectomy for prevention of macular holes. Results of a randomized multicentre clinical trial. Vitrectomy for Prevention of Macular Hole Study Group. Ophthalmol 101: 1055-1059.
18. De Bustros S, Thompson JT, Michels RG, Enger C, Rice TA & Glaser BM (1988): Nuclear sclerosis after vitrectomy for idiopathic epiretinal membranes. Am J Ophthalmol 105: 160-164.
19. Duke-Elder S & Dobree JH (1967): System of Ophthalmology. Vol. X. Diseases of the Retina. London: Henry Kimpton. 1-878.
20. Duker JS, Wendel R, Patel AC & Puliafito CA (1994): Late re-opening of macular holes after initially successful treatment with vitreous surgery. Ophthalmology 101: 1373-1378.
21. Engelbrecht NE, Freeman J, Sternberg P, Aaberg TM, Aaberg TM, Martin DF & Sippy BD (2002): Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 133: 89-94.
22. Eye Disease Case-Control Study Group. (1994): Risk factors for idiopathic macular holes. Am J Ophthalmol 118: 754-761.
23. Ezra E (2001): Idiopathic full thickness macular hole: natural history and pathogenesis. Br J Ophthalmol 85: 102-108.
24. Ezra E, Fariss RN, Possin DE, Aylward WG, Gregor ZJ, Luthert PJ & Milam AH (2001): Immunocytochemical characterization of macular hole opercula. Arch Ophthalmol 119: 223-231.
25. Ezra E, Munro PM, Charteris DG, Aylward WG, Luthert PJ & Gregor ZJ (1997): Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol 115: 1381-1387.
26. Ezra E, Wells JA, Gray RH, Kinsella FM, Orr GM, Grego J, Arden GB & Gregor ZJ (1998): Incidence of idiopathic full thickness macular holes in fellow eyes. A 5-year prospective natural history study. Ophthalmology 105: 353-359.
27. Freeman WR, Azen SP, Kim JW, el Haig W, Mishell DR III & Bailey I (1997): Vitrectomy for the treatment of full thickness stage 3 or 4 macular holes. Results of a multicentred randomized clinical trial. Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol 115: 11-21.
28. Gass JD (1988): Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol 106: 629-639.
29. Gass JD (1995): Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 119: 752-759.
30. Gass JD (1999): Muller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacular retinoschisis. Arch Ophthalmol 117: 821-823.
31. Gass CA, Haritoglou C, Messmer EM, Schaumberger M & Kampik A (2001): Peripheral visual field defects after macular hole surgery: a complication with decreasing incidence. Br J Ophthalmol 85: 549-551.
32. Gass JD & Joondeph BC (1990): Observations concerning patients with suspected impending macular holes. Am J Ophthalmol 109: 638-646.
33. Gaudric A, Haouchine B, Massin P, Paques M, Blain P & Erginay A (1999): Macular hole formation: new data provided by optical coherence tomography. Arch Ophthalmol 117: 744-751.
34. Goldbaum MH, McCuen BW, Hanneken AM, Burgess SK & Chen HH (1998): Silicone oil tamponade to seal macular holes without position restrictions. Ophthalmology 105: 2140-2147.
35. Haller JA (1999): Clinical characteristics and epidemiology of macular holes. In: Madreperla SA & McCuen BW (eds). Macular Hole. Pathogenesis, Diagnosis and Treatment. Boston: Butterworth Heinemann. 25-36.
36. Haouchine B, Massin P & Gaudric A (2001): Foveal pseudocyst as the first step in macular hole formation: a prospective study by optical coherence tomography. Ophthalmology 108: 15-22.
37. Haritoglou C, Ehrt O, Gass CA, Kristin N & Kampik A (2001): Paracentral scotomata: a new finding after vitrectomy for idiopathic macular hole. Br J Ophthalmol 85: 231-233.
38. Hikichi T, Akiba J & Trempe CL (1993): Effect of the vitreous on the prognosis of full thickness idiopathic macular hole. Am J Ophthalmol 116: 273-278.
39. Hikichi T & Trempe CL (1993): Risk of decreased visual acuity in full thickness idiopathic macular holes. Am J Ophthalmol 116: 708-712.
40. Hikichi T, Yoshida A, Akiba J, Konno S & Trempe CL (1995a): Prognosis of stage 2 macular holes. Am J Ophthalmol 119: 571-575.
41. Hikichi T, Yoshida A, Akiba J & Trempe CL (1995b): Natural outcomes of stage 1, 2, 3 and 4 idiopathic macular holes. Br J Ophthalmol 79: 517-520.
42. Hirata A, Yonemura N, Hasumura T, Murata Y & Negi A (2000): Effect of infusion air pressure on visual field defects after macular hole surgery. Am J Ophthalmol 130: 611-616.
43. Jensen OM & Larsen M (1998): Objective assessment of photoreceptor displacement and metamorphopsia: a study of macular holes. Arch Ophthalmol 116: 1303-1306.
44. Johnson RN & Gass JD (1988): Idiopathic macular holes. Observations, stages of formation and implications for surgical intervention. Ophthalmology 95: 917-924.
45. Johnson MW, Van Newkirk MR & Meyer KA (2001): Perifoveal vitreous detachment is the primary pathogenic event in idiopathic macular hole formation. Arch Ophthalmol 119: 215-222.
46. Jumper JM, Gallemore RP, McCuen BW & Toth CA (2000): Features of macular hole closure in the early postoperative period using optical coherence tomography. Retina 20: 232-237.
47. Kakehashi A, Schepens CL, Akiba J, Hikichi T & Trempe CL (1995): Spontaneous resolution of foveal detachments and macular breaks. Am J Ophthalmol 120: 767-775.
48. Kakehashi A, Schepens CL & Trempe CL (1996): Vitreomacular observations. II. Data on the pathogenesis of idiopathic macular breaks. Graefes Arch Clin Exp Ophthalmol 234: 425-433.
49. Kang HK, Chang AA & Beaumont PE (2000): The macular hole: report of an Australian surgical series and meta-analysis of the literature. Clin Experiment Ophthalmol 28: 298-308.
50. Karia N, Laidlaw A, West J, Ezra E & Gregor MZ (2001): Macular hole surgery using silicone oil tamponade. Br J Ophthalmol 85: 1320-1323.
51. Kelly NE & Wendel RT (1991): Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 109: 654-659.
52. Kim JW, Freeman WR, Azen SP, el Haig W, Klein DJ & Bailey IL (1996): Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group. Am J Ophthalmol 121: 605-614.
53. Kim JW, Freeman WR, el Haig W, Maguire AM, Arevalo JF & Azen SP (1995): Baseline characteristics, natural history and risk factors to progression in eyes with stage 2 macular holes. Results from a prospective randomized clinical trial. Vitrectomy for Macular Hole Study Group. Ophthalmol 102: 1818-1828.
54. Kishi S, Kamei Y & Shimizu K (1995): Tractional elevation of Henle's fibre layer in idiopathic macular holes. Am J Ophthalmol 120: 486-496.
55. Klein BR, Hiner CJ, Glaser BM, Murphy RP, Sjaarda RN & Thompson JT (1995): Fundus photographic and fluorescein angiographic characteristics of pseudoholes of the macula in eyes with epiretinal membranes. Ophthalmology 102: 768-774.
56. Klein R, Klein BE, Wang Q & Moss SE (1994): The epidemiology of epiretinal membranes. Trans Am Ophthalmol Soc 92: 403-425.
57. Kokame GT & De Bustros S (1995): Visual acuity as a prognostic indicator in stage I macular holes. Vitrectomy for Prevention of Macular Hole Study Group. Am J Ophthalmol 120: 112-114.
58. Kotecha AV, Sinclair SH, Gupta AK & Tipperman R (2000): Pars plana vitrectomy for macular holes combined with cataract extraction and lens implantation. Ophthalmic Surg Lasers 31: 387-393.
59. Kumar V, Banerjee S, Loo AV, Callear AB & Benson MT (2002): Macular hole surgery with silicone oil. Eye 16: 121-125.
60. Kwok AK & Lai TY (2002): ILM peeling in macular hole surgery. Ophthalmology 109: 822-823.
61. Leonard RE, Smiddy WE, Flynn HW Jr & Feuer W (1997): Long-term visual outcomes in patients with successful macular hole surgery. Ophthalmology 104: 1648-1652.
62. Lewis ML, Cohen SM, Smiddy WE & Gass JD (1996): Bilaterality of idiopathic macular holes. Graefes Arch Clin Exp Ophthalmol 234: 241-245.
63. Madreperla SA, McCuen BW, Hickingbotham D & Green WR (1995): Clinicopathologic correlation of surgically removed macular hole opercula. Am J Ophthalmol 120: 197-207.
64. Margherio RR, Margherio AR, Williams GA, Chow DR & Banach MJ (2000a): Effect of perifoveal tissue dissection in the management of acute idiopathic full thickness macular holes. Arch Ophthalmol 118: 495-498.
65. Martinez J, Smiddy WE, Kim J & Gass JD (1994): Differentiating macular holes from macular pseudoholes. Am J Ophthalmol 117: 762-767.
66. Melberg NS & Thomas MA (1995): Visual field loss after pars plana vitrectomy with air/fluid exchange. Am J Ophthalmol 120: 386-388.
67. Mester V & Kuhn F (2000): Internal limiting membrane removal in the management of full thickness macular holes. Am J Ophthalmol 129: 769-777.
68. Mikajiri K, Okada AA, Ohji M et al. (1999): Analysis of vitrectomy for idiopathic macular hole by optical coherence tomography. Am J Ophthalmol 128: 655-657.
69. Mitchell P, Smith W, Chey T, Wang JJ & Chang A (1997): Prevalence and associations of epiretinal membranes. Blue Mountains Eye Study. Ophthalmol 104: 1033-1040.
70. Paques M, Chastang C, Mathis A et al. (1999): Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicentre, double-masked, randomized trial. Platelets in Macular Hole Surgery Group. Ophthalmol 106: 932-938.
71. Paques M, Massin P, Blain P, Duquesnoy AS & Gaudric A (2000): Long-term incidence of reopening of macular holes. Ophthalmology 107: 760-765.
72. Park DW, Sipperley JO, Sneed SR, Dugel PU & Jacobsen J (1999): Macular hole surgery with internal limiting membrane peeling and intravitreous air. Ophthalmology 106: 1392-1397.
73. Park SS, Marcus DM, Duker JS, Pesavento RD, Topping TM, Frederick AR Jr & D'Amico DJ (1995): Posterior segment complications after vitrectomy for macular hole. Ophthalmology 102: 775-781.
74. Pearce IA, Branley M, Groenewald C, McGalliard J & Wong D (1998): Visual function and patient satisfaction after macular hole surgery. Eye 12: 651-658.
75. Pendergast SD & McCuen BW (1996): Visual field loss after macular hole surgery. Ophthalmology 103: 1069-1077.
76. Rahmani B, Tielsch JM, Katz J, Gottsch J, Quigley H, Javitt J & Sommer A (1996): The cause-specific prevalence of visual impairment in an urban population. Baltimore Eye Survey. Ophthalmol 103: 1721-1726.
77. Rice TA (1999): Internal limiting membrane removal in surgery for full thickness macular holes. In: Madreperla SA & McCuen BW (eds). Macular Hole. Pathogenesis, Diagnosis and Treatment. Boston: Butterworth Heinemann. 125-146.
78. Ryan EH Jr & Gilbert HD (1994): Results of surgical treatment of recent onset, full thickness idiopathic macular holes. Arch Ophthalmol 112: 1545-1553.
79. Saito Y, Hirata Y, Hayashi A, Fujikado T, Ohji M & Tano Y (2000): The visual performance and metamorphopsia of patients with macular holes. Arch Ophthalmol 118: 41-46.
80. Scott RA, Ezra E, West JF & Gregor ZJ (2000): Visual and anatomical results of surgery for longstanding macular holes. Br J Ophthalmol 84: 150-153.
81. Simcock PR & Scalia S (2000): Phako-vitrectomy for full thickness macular holes. Acta Ophthalmol Scand 78: 684-686.
82. Smiddy WE, Feuer W & Cordahi G (2001): Internal limiting membrane peeling in macular hole surgery. Ophthalmology 108: 1471-1476.
83. Smiddy WE, Pimentel S & Williams GA (1997): Macular hole surgery without using adjunctive additives. Ophthalmic Surg Lasers 28: 713-717.
84. Takahashi H & Kishi S (2000): Tomographic features of a lamellar macular hole formation and a lamellar hole that progressed to a full thickness macular hole. Am J Ophthalmol 130: 677-679.
85. Tanner V, Chauhan DS, Jackson TL & Williamson TH (2001): Optical coherence tomography of the vitreoretinal interface in macular hole formation. Br J Ophthalmol 85: 1092-1097.
86. Tanner V & Williamson TH (2000): Watzke-Allen slit beam test in macular holes confirmed by optical coherence tomography. Arch Ophthalmol 118: 1059-1063.
87. Terasaki H, Miyake Y, Nomura R, Piao CH, Hori K, Niwa T & Kondo M (2001): Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci 42: 229-234.
88. Thompson JT, Glaser BM, Sjaarda RN & Murphy RP (1995): Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol 119: 48-54.
89. Thompson JT, Hiner CJ, Glaser BM, Gordon AJ, Murphy RP & Sjaarda RN (1994): Fluorescein angiographic characteristics of macular holes before and after vitrectomy with transforming growth factor beta-2. Am J Ophthalmol 117: 291-301.
90. Thompson JT, Smiddy WE, Williams GA, Sjaarda RN, Flynn HW Jr, Margherio RR & Abrams GW (1998): Comparison of recombinant transforming growth factor beta-2 and placebo as an adjunctive agent for macular hole surgery. Ophthalmology 105: 700-706.
91. Tornambe PE, Poliner LS & Grote K (1997): Macular hole surgery without face-down positioning. A pilot study. Retina 17: 179-185.
92. Trempe CL, Weiter JJ & Furukawa H (1986): Fellow eyes in cases of macular hole. Biomicroscopic study of the vitreous. Arch Ophthalmol 104: 93-95.
93. Ullrich S, Haritoglou C, Gass C, Schaumberger M, Ulbig MW & Kampik A (2002): Macular hole size as a prognostic factor in macular hole surgery. Br J Ophthalmol 86: 390-393.
94. Weinberger AW, Kirchhof B, Mazinani BE & Schrage NF (2001): Persistent indocyanine green (ICG) fluorescence 6 weeks after intraocular ICG administration for macular hole surgery. Graefes Arch Clin Exp Ophthalmol 239: 388-390.
95. Wendel RT, Patel AC, Kelly NE, Salzano TC, Wells JW & Novack GD (1993): Vitreous surgery for macular holes. Ophthalmology 100: 1671-1676.
96. Willis AW & Garcia-Cosio JF (1996): Macular hole surgery. Comparison of longstanding versus recent macular holes. Ophthalmology 103: 1811-1814.